A leading full-service global contract research organization that works to create customized solutions that advance new medications – from discovery to reality.
We’re no longer posting on X, but our commitment to sharing insights and connecting with you continues. Follow us on LinkedIn to stay engaged with Worldwide Clinical Trials. We’ll see you there! 👇
https://t.co/GYDo0wDIzh
Interested in how we optimize our bioanalytical instruments? Check out how we expedite study timelines through our bioanalysis automation methods:
https://t.co/iiCao4vPSp
The oncology clinical trials market is experiencing explosive growth – and with growth comes barriers. In this @IntClinTrials article, Teleen Norman and Clare Wallis explore how an integrated CRO/sponsor culture can help overcome these barriers. https://t.co/OW8qNlpgSL
At this year’s Global Genes RARE Advocacy Summit, our Amy Raymond will present “Gene Replacement and Gene Editing Therapies” tomorrow at 10 AM. See more details here:
https://t.co/54NH4MUCqF
A vital part of our #EarlyPhase team is our Clinical Pharmacology Unit (CPU), recently accredited by CAP @Pathologists. Learn how this upholds our culture of quality and adds value for our customers: https://t.co/fd5BoVh7OI
Find out how we managed the Phase III trial for the FDA-approved drug, lecanemab, for Alzheimer’s disease, which included more than 230 sites across 14 countries:
https://t.co/HR7D57sIqh
Get the customized and flexible support you need for your next program from our Cell & Gene Therapy Hub. Meet the team, and see how they adapt to fit your individual needs:
https://t.co/OwtAHydGDo
At Worldwide, we offer comprehensive support services for Phase I and beyond. Check out our service offerings and let us know how we can help with your next study.
https://t.co/oUGdHttQRT
Providing an overview of biomarker development within oncology, this white paper contains valuable insights into the future of oncology drug development:
https://t.co/ZAwOc8OMQo
Registry studies can be used as an observational approach to understand the patient population in terms of the indication’s epidemiology, progression, and prevalence. Find out what else you can learn from registry studies in our article:
https://t.co/hikYvRzKM8
"Blockchain can be used for anything," according to our Aman Khera – including empowering patients. Learn more in this @ClinicalLeader1 article: https://t.co/Cy7yD9z5tf
With an average of 11 years of experience supporting oncology development, our European team utilizes Worldwide’s global resources and local standards of care knowledge to optimize your trial design. Learn more about the team here:
https://t.co/I90JPgvLUF
Strong CRO-biotech partnerships can lead to expedited recruitment, enhanced retention, and improved scientific methodology. Find out how we enabled this with our collaboration on a Phase III ALS study:
https://t.co/XGFzrah0Dd
Curious about what a biotech-focused CRO can do for you? Check out the ways Worldwide personalizes our approach for biotechs in our blog:
https://t.co/zrZh3Hx7Iv
Check out Jen Davis’s main takeaways after five days of informative conference sessions and networking at Psychedelic Science 2023.
https://t.co/IWTbG1ECvy
Pharmacists play a critical role in ensuring patients and trial personnel remain safe in the early phases of your trial. Download our white paper to learn more.
https://t.co/Y37N7olk85